abrdn Life Sciences Investors (HQL) vs Voya Global Advantage and Premium Opportunity Fund (IGA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 8.1x for Voya Global Advantage and Premium Opportunity Fund). abrdn Life Sciences Investors offers the higher dividend yield (11.01% vs 10.36%).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | HQL | IGA |
|---|---|---|
| Share price | $17.35 | $9.85 |
| 1-day change | -1.20% | +0.61% |
| YTD return | +4.65% | — |
| 1-year return | +11.21% | — |
| 5-year return | -15.00% | — |
| P/E ratio (TTM) | 2.61 | 8.07 |
| EPS (TTM) | $6.64 | $1.22 |
| Dividend yield | 11.01% | 10.36% |
| Annual dividend | $1.91 | $1.02 |
| 52-week high | $22.67 | $10.77 |
| 52-week low | $15.66 | $9.21 |
| Distance from 52-week high | -23.47% | -8.54% |
| Average volume | 147.31K | 81.72K |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Voya Global Advantage and Premium Opportunity Fund trades at a higher earnings multiple (8.1x vs 2.6x trailing P/E).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
HQL vs IGA FAQ
Which has the lower P/E ratio, HQL or IGA?
HQL has the lower trailing P/E at 2.6, versus 8.1 for IGA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Voya Global Advantage and Premium Opportunity Fund?
abrdn Life Sciences Investors has the higher yield at 11.01%, compared with 10.36% for Voya Global Advantage and Premium Opportunity Fund.
Are abrdn Life Sciences Investors and Voya Global Advantage and Premium Opportunity Fund in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.